When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Cancer breakthrough as scientists find way to spot aggressive tumours before they spread - The discovery could pave the way ...

How common is endometrial cancer? In the United States, cancer of the endometrium (the lining of the uterus) is the most common cancer of the female reproductive organs. The American Cancer Society ...

A 58-year-old woman mistook her womb cancer symptoms for menopause until her stomach became swollen. Diagnosed with ...

Dawn Willis, 58, had been experiencing vaginal bleeding for about a year, but assumed it was a symptom of the menopause.

Dawn Willis, 58, is now cancer-free and is speaking out in the hopes of raising awareness and hopefully “saving someone’s life.” ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

A new nanomedicine drug delivery system improves chemotherapy targeting for choriocarcinoma, shrinking tumors by 95% in mouse models. Researchers engineered polymersomes to enhance methotrexate (MTX) ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation for Acrivon Therapeutics’ ACR-368 ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...